This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Cytori Therapeutics Inc
CYTX : NASDAQ : Health Care
$2.21 | %
Today's Range: 0.00 - 0.00
Avg. Daily Volume: 363,500
07/10/14 - 3:59 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
CYTX CYTORI THERAPEUTICS INC 2.39 190.02 n/m 9.87 -41.16
CYTR CYTRX CORP 4.17 232.59 n/m 0.30 200.00
BTX BIOTIME INC 3.11 224.38 n/m 4.89 26.11
NBS NEOSTEM INC 6.47 219.47 n/m 16.20 23.84
PSTI PLURISTEM THERAPEUTICS INC 3.08 209.17 n/m 0.38 -44.53
STML STEMLINE THERAPEUTICS INC 14.51 192.17 n/m 0.14 n/a
SRNE SORRENTO THERAPEUTICS INC 6.79 188.88 n/m 1.30 114.14
CYTK CYTOKINETICS INC 4.87 178.29 n/m 37.81 476.31
BSTC BIOSPECIFICS TECHNOLOGIES CP 27.30 174.58 40.15 13.25 5.66
FCSC FIBROCELL SCIENCE INC 4.26 174.05 n/m 0.22 34.96
ISR ISORAY INC 2.96 161.00 n/m 4.51 -1.83
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

CYTX Ind Avg S&P 500
n/m 58.63 19.71

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs